§ 13F · FUND PROFILE
SymBiosis Capital Partners, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 11Turnover · — · Q4Filed · Feb 12, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$109.5T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 12, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | EVMN | Evommune, Inc. | 1.28M | $21.9T | 20.0% | NEW |
| 2 | VSTM | Verastem Inc | 2.00M | $15.4T | 14.1% | NEW |
| 3 | AMPG | Aldeyra Therapeutics Inc | 2.56M | $13.2T | 12.1% | NEW |
| 4 | PGEN | Precigen Inc | 3.00M | $12.5T | 11.5% | NEW |
| 5 | IVA | Inventiva S.A. | 2.60M | $12.1T | 11.0% | NEW |
| 6 | NUVB | Nuvation Bio Inc | 1.25M | $11.2T | 10.2% | NEW |
| 7 | RANI | Rani Therapeutics Holdings, Inc. | 6.30M | $8.5T | 7.8% | NEW |
| 8 | AARD | Aardvark Therapeutics, Inc. | 477K | $6.3T | 5.7% | NEW |
| 9 | CLNN | Clene Nanomedicine Inc. | 770K | $4.5T | 4.1% | NEW |
| 10 | — | Generation Bio Co | 665K | $3.8T | 3.4% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SYMBIOSIS SIGNAL
AC read
SymBiosis Capital Partners, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed